Results 11 to 20 of about 999,769 (295)

Spatial and temporal variability of idiopathic pulmonary fibrosis cases in Silesian Voivodeship in years 2006–2010 [PDF]

International Journal of Occupational Medicine and Environmental Health, 2017
Objectives: Idiopathic pulmonary fibrosis (IPF) (J84.1 by the International Statistical Classification of Diseases and Related Health Problems, 10th revision – ICD-10) is a rare disease of unknown cause.
Ewa Niewiadomska, Małgorzata Kowalska, Jan E. Zejda   +2 more
doaj   +3 more sources

Epidemiology of idiopathic pulmonary fibrosis

Clinical Epidemiology, 2013
Brett Ley, Harold R Collard Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, California, USA Abstract: Idiopathic pulmonary fibrosis is a chronic fibrotic lung disease of ...
Ley B, Collard HR
doaj   +1 more source

Pirfenidone treatment of idiopathic pulmonary fibrosis [PDF]

Therapeutics and Clinical Risk Management, 2011
Ye Gan1,2, Erica L Herzog2, Richard H Gomer31Department of Medicine, Central South University, Changsha, Hunan, China; 2Department of Medicine, Yale University School of Medicine, New Haven, CT, USA; 3Department of Biology, Texas A&M University ...
Ye Gan, Erica L Herzog, Richard H Gomer
doaj   +2 more sources

Common idiopathic pulmonary fibrosis risk variants are associated with hypersensitivity pneumonitis [PDF]

, 2021
A subset of patients with hypersensitivity pneumonitis (HP) develop lung fibrosis that is clinically similar to idiopathic pulmonary fibrosis (IPF). To address the aetiological determinants of fibrotic HP, we investigated whether the common IPF genetic ...
Lee, Joyce S, Peljto, Anna, Molyneaux, Philip, Fernández Pérez, Evans, Wolters, Paul, Schwartz, David A, Cardwell, Jonathan, Yang, Ivana V, Yang, Ivana, Lee, Joyce, Walts, Avram, Peljto, Anna L, Molyneaux, Philip L, Furusawa, Haruhiko, Schwartz, David, Wolters, Paul J, Fernández Pérez, Evans R, Walts, Avram D   +17 more
core   +1 more source

Clinical relevance of circulating autoantibodies in idiopathic pulmonary fibrosis; A NAt hard to break

Frontiers in Medicine, 2022
Patients with idiopathic pulmonary fibrosis are screened for circulating autoantibodies as part of the initial interstitial lung disease workup. Management of seropositive idiopathic pulmonary fibrosis is currently considered no different than that of ...
Paraskevi Kirgou, Sotirios I. Sinis, Ilias E. Dimeas, Ilias C. Papanikolaou, Konstantinos Tatsis, Athena Gogali, Konstantinos I. Gourgoulianis, Dimitrios P. Bogdanos, Zoe Daniil   +8 more
doaj   +1 more source

Radiological findings based comparison of functional status in patients who have post-covid lung injury or idiopathic pulmonary fibrosis

BMC Pulmonary Medicine, 2023
Background Following COVID-19 infection, some patients acquired lung injury and fibrosis. Idiopathic pulmonary fibrosis is characterized by lung fibrosis.
Deniz Kızılırmak, Seçil Sarı, Fatma Can, Yavuz Havlucu   +3 more
doaj   +1 more source

The Role of DNA Damage and Repair in Idiopathic Pulmonary Fibrosis

Antioxidants, 2022
The mortality rate of idiopathic pulmonary fibrosis (IPF) increases yearly due to ineffective treatment. Given that the lung is exposed to the external environment, it is likely that oxidative stress, especially the stimulation of DNA, would be of ...
Jiahui Zhu, Lexin Liu, Xiaodi Ma, Xinyu Cao, Yu Chen, Xiangping Qu, Ming Ji, Huijun Liu, Chi Liu, Xiaoqun Qin, Yang Xiang   +10 more
doaj   +1 more source

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis

Frontiers in Pharmacology, 2022
Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal fibrotic lung disease that occurs primarily in middle-aged and elderly adults. It is a major cause of morbidity and mortality. With an increase in life expectancy, the economic burden of IPF is
Qian Mei, Zhe Liu, He-Ning Zuo, Zhen-Hua Yang, Jing Qu   +4 more
semanticscholar   +1 more source

Idiopathic pulmonary fibrosis: Current and future treatment

Clinical Respiratory Journal, 2022
Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic lung disease characterized by dry cough, fatigue, and progressive exertional dyspnea. Lung parenchyma and architecture is destroyed, compliance is lost, and gas exchange is compromised in this ...
Daniel S. Glass, D. Grossfeld, Heather A. Renna, Priya Agarwala, P. Spiegler, J. De Leon, A. Reiss   +6 more
semanticscholar   +1 more source

Lung Cancer in Pulmonary Fibrosis: Tales of Epithelial Cell Plasticity [PDF]

, 2011
Lung epithelial cells exhibit a high degree of plasticity. Alterations to lung epithelial cell function are critically involved in several chronic lung diseases such as pulmonary fibrosis.
Königshoff, M., Melanie Königshoff, Königshoff, Melanie   +2 more
core   +1 more source